Max Healthcare Institute Limited vs Aster DM Quality Care Limited
An objective side-by-side of MAXHEALTH and ASTERDM, both in Healthcare: valuation, profitability, growth, balance sheet, ownership and share-price performance. Where one number is clearly better on its own terms (lower P/E, higher ROE), it is shaded. That is a description, not a recommendation.
Prices as of 2026-11-12 close
Latest results: MAXHEALTH Sep 2026 · ASTERDM Sep 2026
At a glance
- Max Healthcare Institute Limited is the larger company by market value, about 1.4 times the size of Aster DM Quality Care Limited.
- On trailing earnings, Max Healthcare Institute Limited trades at the lower P/E (66.7 against 113.6).
- Max Healthcare Institute Limited earns the higher return on equity (12.2% against 7.3%).
- Over three years Max Healthcare Institute Limited has grown profits faster (10% a year against -1%).
- Over the past year the share prices returned -15.9% (MAXHEALTH) and +7.1% (ASTERDM).
| Metric | Max Healthcare MAXHEALTH |
Aster DM ASTERDM |
|---|---|---|
| Size and price | ||
| Market cap | ₹92,104 Cr | ₹64,146 Cr |
| Share price | ₹946.30 | ₹735.90 |
| Valuation | ||
| P/E | 66.73 | 113.60 |
| P/B | 8.13 | 8.25 |
| EV/EBITDA | 39.07 | 51.77 |
| PEG | 6.67 | — |
| Dividend yield | 0.2% | 0.7% |
| Profitability | ||
| ROE | 12.2% | 7.3% |
| ROCE | 15.0% | 11.0% |
| Operating margin | 26.8% | 20.8% |
| Sales (TTM) | ₹9,146 Cr | ₹6,508 Cr |
| Net profit (TTM) | ₹1,380 Cr | ₹565 Cr |
| Growth | ||
| Latest quarter sales YoY | +20.3% | +136.4% |
| Latest quarter profit YoY | -15.6% | +166.4% |
| Sales CAGR 3Y | +22.0% | +16.0% |
| Profit CAGR 3Y | +10.0% | -1.0% |
| Sales CAGR 5Y | +27.0% | -12.0% |
| Profit CAGR 5Y | +60.0% | +23.0% |
| Financial strength | ||
| Debt/Equity | 0.33 | 0.76 |
| Interest cover | 7.63 | 4.88 |
| Ownership | ||
| Promoter holding | 23.7% | 53.8% |
| Promoter change (4 qtrs) | -0.03 pp | +13.40 pp |
| Price performance | ||
| Return 1M | +9.28% | +8.32% |
| Return 3M | -9.01% | -13.92% |
| Return 1Y | -15.91% | +7.08% |
| Return YTD | -9.45% | +19.30% |
| Technical condition | ||
| Technical score | 72 | 70 |
| RS rating (1-99) | 39.00 | 65.00 |
| % vs 200-DMA | -6.29% | +2.48% |
| RSI (14) | 62.13 | 61.66 |
| % from 52-week high | -20.17% | -17.44% |
